ORAMED PHARMACEUTICALS INC. Other Non-Current Liabilities
ORAMED PHARMACEUTICALS INC. (ORMP) had Other Non-Current Liabilities of $60.00 thousand as of 2024-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-03-26
- 2024-12-31: Other Liabilities, Noncurrent $60.00K.
- 2024-09-30: Other Liabilities, Noncurrent $60.00K.
- 2024-06-30: Other Liabilities, Noncurrent $60.00K.
- 2023-12-31: Other Liabilities, Noncurrent $63.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2024-12-31 | $60.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $60.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $60.00K 10-Q · filed 2024-08-14 |
| 2023-12-31 | $63.00K 10-K · filed 2025-03-27 |
| 2021-05-31 | $160.00K 10-Q · filed 2021-07-14 |
| 2021-02-28 | $177.00K 10-Q · filed 2021-04-13 |
| 2020-11-30 | $212.00K 10-Q · filed 2021-01-14 |
| 2020-08-31 | $211.00K 10-Q · filed 2021-07-14 |
| 2020-05-31 | $194.00K 10-Q · filed 2020-07-07 |
| 2020-02-29 | $232.00K 10-Q · filed 2020-04-06 |
| 2019-11-30 | $270.00K 10-Q · filed 2020-01-09 |
| 2019-08-31 | $271.00K 10-K · filed 2020-11-24 |
| 2019-05-31 | $288.00K 10-Q · filed 2019-07-10 |
| 2019-02-28 | $306.00K 10-Q · filed 2019-04-10 |
| 2018-11-30 | $281.00K 10-Q · filed 2019-01-14 |
| 2018-08-31 | $313.00K 10-K · filed 2019-11-27 |
| 2018-05-31 | $330.00K 10-Q · filed 2018-07-12 |
| 2018-02-28 | $404.00K 10-Q · filed 2018-04-09 |
| 2017-11-30 | $423.00K 10-Q · filed 2018-01-11 |
| 2017-08-31 | $443.00K 10-K · filed 2018-11-28 |
| 2017-05-31 | $462.00K 10-Q · filed 2017-07-06 |
| 2017-02-28 | $481.00K 10-Q · filed 2017-04-05 |
| 2016-11-30 | $501.00K 10-Q · filed 2017-01-11 |
| 2016-08-31 | $390.00K 10-K · filed 2017-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |